查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888704

勝任細胞市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測（2025-2033 年）

Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

勝任細胞市場摘要

2024年全球勝任細胞市場規模估計為22.5億美元，預計2033年將達到51.2億美元。

預計2025年至2033年間，該市場將以10.03%的複合年成長率成長，主要驅動力包括先進分子克隆技術的日益普及、重組蛋白需求的成長以及在藥物研發和生物技術研究領域應用範圍的擴大。基因工程和合成生物學的進步預計將在整個預測期內持續提升對高效能、高性能勝任細胞的需求。

對重組蛋白和酵素的需求不斷成長

重組蛋白和酵素生產的快速成長是勝任細胞市場的主要驅動力。生物製藥公司依賴利用基因工程微生物開發的重組蛋白，例如單株抗體、荷爾蒙、細胞激素和生物相似藥，這些蛋白廣泛應用於食品加工、診斷、生質燃料和生物技術等產業。對於這些應用而言，勝任細胞至關重要，它能夠支持從研究實驗室到大規模生產的克隆和表達工作流程。不斷擴展的生物製劑研發管線和日益成長的創新治療方法需求，要求蛋白質生產具有高轉化效率和高產量，這對勝任細胞的性能提出了越來越高的要求。

此外，合成生物學和代謝工程的創新正在拓展重組酶在永續材料、化學品和生質塑膠的應用。精準發酵和無細胞蛋白合成的持續投入，推動了最佳化型感受態勝任細胞系統的需求。隨著研究機構和生物技術公司專注於克隆速度、可擴展性和更優的表達平台，藥物研發、蛋白質工程和工業生物製造等領域對勝任細胞的需求持續成長。

基因工程和合成生物學的發展

基因工程和合成生物學領域的蓬勃發展是勝任細胞市場的主要驅動力。這些領域需要高效的勝任細胞用於DNA克隆、質體構建、CRISPR基因編輯和微生物工程。隨著研究團隊採用自動化克隆、人工智慧蛋白質設計和先進的基因組編輯工作流程，可靠、高性能勝任細胞的需求持續成長。

同時，合成生物學正迅速發展成為生物製造、永續化學品、生質燃料、精密農業、生物感測器等工業應用領域。隨著微生物菌株工程和高通量篩檢的投資不斷增加，迫切需要建立最佳化的勝任細胞，以實現快速、可擴展和可重複的結果。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章勝任細胞市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 活性細胞市場分析工具
    • 產業分析 - 波特五力
    • PESTEL 分析

第4章勝任細胞市場：按類型分類的估算與趨勢分析

  • 全球勝任細胞市場：按類型分類的差異分析
  • 全球勝任細胞市場規模及趨勢分析（按類型分類，2021-2033年）
  • 化學勝任細胞
  • 勝任細胞
  • 超強勝任細胞

第5章勝任細胞市場：按應用分類的估算與趨勢分析

  • 全球勝任細胞市場：按應用領域分析變化
  • 全球勝任細胞市場規模及應用趨勢分析（2021-2033年）
  • 複製
  • 蛋白質表現
  • 誘變
  • 其他

第6章勝任細胞市場：依最終用途分類的估算與趨勢分析

  • 全球勝任細胞市場：依最終用途分類的差異分析
  • 全球勝任細胞市場規模及應用趨勢分析（2021-2033年）
  • 製藥和生物技術公司
  • 學術和研究機構
  • 其他

第7章勝任細胞市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2024年商業市場分析
  • 公司簡介/列表
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Takara Bio Inc.
    • New England Biolabs（UK）Ltd.
    • Promega Corporation
    • Bio-Rad Laboratories
    • Roche Applied Science
    • Qiagen
    • SGI-DNA（Synthetic Genomics, Inc.）
Product Code: GVR-4-68040-310-3

Competent Cells Market Summary

The global competent cells market size was estimated at USD 2.25 billion in 2024 and is projected to reach USD 5.12 billion by 2033, growing at a CAGR of 10.03% from 2025 to 2033, driven by growing adoption of advanced molecular cloning techniques, increasing demand for recombinant proteins, and expanding uses in drug discovery and biotechnology research. As genetic engineering and synthetic biology advance, the demand for effective and high-performance competent cells is expected to increase throughout the forecast period.

Increasing Demand for Recombinant Proteins & Enzymes

The rapid growth of recombinant protein and enzyme production is a key driver of the competent cells market. Biopharmaceutical firms rely on the use of recombinant proteins, such as monoclonal antibodies, hormones, cytokines, and biosimilars developed from engineered microbes, for applications in food processing, diagnostics, biofuels, and the biotech industry. Competent cells are required to enable clonal and expression workflows in these applications, for both research laboratories and larger-scale manufacturing. Competent cell performance is in high demand as biologics pipelines expand and the need for new and innovative therapies grows, prompting high transformation efficiency and yield during protein production.

In addition, innovations in synthetic biology and metabolic engineering are expanding the applications of recombinant enzymes in sustainable materials, chemicals, and bioplastics. Increased investments in precision fermentation and cell-free protein synthesis create increased demand for optimized competent cell systems. As research institutions and biotech companies focus on cloning speed, scalability, and better expression platforms, demand for competent cells continues to grow for drug discovery, protein engineering, and industrial biomanufacturing applications.

Growth in Genetic Engineering & Synthetic Biology

The growing areas of genetic engineering and synthetic biology are primary factors in the competent cells market. These areas rely on competent cells with high efficiency for DNA cloning, plasmid construction, CRISPR editing, and microbial engineering. Demand for reliable, high-performance competent cells continues to grow as research groups implement automated cloning, AI protein design, and sophisticated genome-editing workflows.

At the same time, synthetic biology is rapidly developing into industrial applications, including biomanufacturing, sustainable chemicals, biofuels, precision agriculture, and biosensors. Increased investment in microbial strain engineering and high-throughput screening is putting pressure on finding optimized competent cell lines that enable rapid, scalable, and reproducible results.

Global Component Cells Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global competent cells market on the basis of type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Chemically Competent Cells
  • Electrocompetent Cells
  • Ultracompetent Cells
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloning
  • Protein Expression
  • Mutagenesis
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Competent Cells Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for recombinant proteins & enzymes
      • 3.2.1.2. Growth in genetic engineering & synthetic biology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Costs of Competent Cells
  • 3.3. Competent Cells Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Competent Cells Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Competent Cells Market Type Movement Analysis
  • 4.3. Global Competent Cells Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Chemically Competent Cells
    • 4.4.1. Chemically competent cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Electrocompetent Cells
    • 4.5.1. Electrocompetent cells market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Ultracompetent Cells
    • 4.6.1. Ultracompetent cells market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Competent Cells Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Competent Cells Market Application Movement Analysis
  • 5.3. Global Competent Cells Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Cloning
    • 5.4.1. Cloning market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Protein Expression
    • 5.5.1. Protein expression market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Mutagenesis
    • 5.6.1. Mutagenesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competent Cells Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Competent Cells Market End-use Movement Analysis
  • 6.3. Global Competent Cells Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competent Cells Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Takara Bio Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. New England Biolabs (UK) Ltd.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Bio-Rad Laboratories
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Roche Applied Science
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Qiagen
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. SGI-DNA (Synthetic Genomics, Inc.)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global competent cells market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 4 Global competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 North America competent cells market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 8 North America competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 10 U.S. competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 11 U.S. competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 13 Canada competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 14 Canada competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Mexico competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 17 Mexico competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 19 Europe competent cells market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 21 Europe competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 Germany competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 24 Germany competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 25 Germany competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 26 UK competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 27 UK competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 28 UK competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 France competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 30 France competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 31 France competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 32 Italy competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 33 Italy competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 35 Spain competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 36 Spain competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 38 Denmark competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 39 Denmark competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Sweden competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 42 Sweden competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Norway competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 45 Norway competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific competent cells market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 China competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 52 China competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 53 China competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 54 Japan competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 55 Japan competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 57 India competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 58 India competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 59 India competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 60 South Korea competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 61 South Korea competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 63 Australia competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 64 Australia competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Thailand competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 67 Thailand competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 69 Latin America competent cells market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 71 Latin America competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 73 Brazil competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 74 Brazil competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Argentina competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 77 Argentina competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 79 MEA competent cells market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 81 MEA competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 83 South Africa competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 84 South Africa competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 89 UAE competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 90 UAE competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE competent cells market, by end-use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait competent cells market, by type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait competent cells market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait competent cells market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Competent cells market: Market outlook
  • Fig. 5 Competent cells market: Segment outlook
  • Fig. 6 Competent cells market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Competent cells market driver impact
  • Fig. 9 Competent cells market restraint impact
  • Fig. 10 Competent cells market: Type outlook and key takeaways
  • Fig. 11 Competent cells market: Type movement analysis
  • Fig. 12 Chemically competent cells market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 Electrocompetent cells market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 Ultracompetent cells market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Competent cells market: Application outlook and key takeaways
  • Fig. 16 Competent cells market: Application movement analysis
  • Fig. 17 Cloning market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Protein expression market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Mutagenesis market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 21 Competent cells market: End-use outlook and key takeaways
  • Fig. 22 Competent cells market: End-use movement analysis
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 24 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Global competent cells market: Regional outlook and key takeaways
  • Fig. 27 Global competent cells market: Regional movement analysis
  • Fig. 28 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)